期刊文献+

孟鲁司特治疗小儿哮喘的临床疗效观察 被引量:1

Observation on the clinical curative effect of montelukast in the treatment of children with asthma
下载PDF
导出
摘要 目的:探讨孟鲁司特治疗小儿哮喘的临床疗效。方法:收治哮喘患儿64例,平分为两组,对照组采用常规治疗,观察组在对照组治疗的基础上采用孟鲁司特治疗,对比两组临床疗效。结果:观察组的治疗有效率96.9%,较对照组的78.1%显著提高,差异有统计学意义(P<0.05)。在治疗后,与对照组相比,观察组1 s用力呼气量及最大呼吸流量均显著升高,差异有统计学意义(P<0.05)。结论:孟鲁司特治疗小儿哮喘具有良好效果。 Objective:To investigate the clinical curative effect of montelukast in the treatment of children with asthma.Methods:64 children with asthma were selected.They were divided into the two groups on average.Pateitns in the control group receivedconventional treatment,while patients in the control group were treated with montelukast based on the observation group.Theclinical efficacy of two groups were compared.Results:The effective rate of treatment in the observation group was 96.9%,whichwas significantly higher than that of the control group of 78.1% ,and the difference was statistically significant(P<0.05).Aftertreatment,the 1 second forced expiratory volume and peak flow of the observation group significantly increased compared with thecontrol group,and the difference was statistically significant(P<0.05).Conclusion:Montelukast for the treatment of asthma inchildren has good effect.
作者 张利军 Zhang Lijun(The People's Hospital of Qiannan Prefecture 558000)
机构地区 黔南州人民医院
出处 《中国社区医师》 2016年第12期88-88,90,共2页 Chinese Community Doctors
关键词 孟鲁司特 小儿哮喘 1 s用力呼气量 最大呼吸流量 Montelukast Asthma in children 1 second forced expiratory volume peak flow
  • 相关文献

参考文献4

二级参考文献43

  • 1彭秋莹,陈爱欢.白三烯研究进展及其在婴幼儿喘息性疾病中的作用[J].中华儿科杂志,2006,44(7):553-556. 被引量:94
  • 2赵德育.白三烯受体拮抗剂在儿童支气管哮喘治疗中的地位[J].儿科药学杂志,2007,13(1):4-6. 被引量:49
  • 3沈瑶,金美玲,白春学.慢性咳嗽和白三烯受体拮抗剂[J].国际呼吸杂志,2007,27(7):528-530. 被引量:48
  • 4Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease [J]. Nat Rev Immunol, 2008, 8 ( 3 ) : 183- 192.
  • 5Reuter S,Taube C. Mast cells and the development of allergic airway disease[J]. J Oecup Med Toxicol, 2008,3 (Suppl 1 ) : S2.
  • 6Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma[J]. Resir Med,2006,100(8) :1307-1317.
  • 7Jaeschke R,O'Byme PM, Nair P, et al. The safety of formoteral among patients with ashma using inhaled corticosteroids. Systematic review and meta-anatysis[J]. Pol Arch Med Wewn, 2008,118(11) :627-635.
  • 8Knox AJ, Mortimer K. Combining inhaled glucocorticoids and long acting beta(2)-adrenoceptor agonists in asthma and COPD [J]. Br J pharmacol,2008,153(6) : 1085-1086.
  • 9Owen CE. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic[J]. Pharmacol Ther, 2007,113 (1) :121-133.
  • 10Casale TB, Stokes JR. Immunomodutators for allergic respiratory disorders[J]. J Allergy Clin Immunol, 2008, 121 (2) :288-296.

共引文献61

同被引文献15

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部